Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award - Priority Announcement - Schizophrenia (SHOPP)

University of British Columbia

$52,500.00

Differential effects of cognitive remediation therapy and metacognitive training on symptoms, cognition, and functional brain activity in schizophrenia

EF 2012-13

Résumé
Schizophrenia is a debilitating disorder that severely impacts the lives of patients and their families. Despite major improvements to the medications used to treat schizophrenia, they are not always effective at improving symptoms, memory and attention, or social functioning. For these reasons, health professionals are actively searching for complementary treatment options that can be used alongside conventional medications. Cognitive training is one of the most common and effective of these alternative treatments, and has been found to improve symptoms, social functioning, as well as memory and attention. However, different types of therapy target different aspects of schizophrenia, and it is important to understand their distinct effects to better tailor treatment to a patient's needs. The goal of this research is to examine whether two cognitive therapies, cognitive remediation therapy (CRT) and metacognitive training (MCT), show distinct benefits to schizophrenia patients. CRT uses training and practice to improve memory and attention whereas MCT focuses on teaching patients to counteract biases in thinking that contribute to symptoms. In this study, groups of 10 schizophrenia patients will take part in either CRT or MCT over an 8-week period, and we will examine changes in social functioning, symptom severity, memory/attention, and brain activity. This research will be the first direct comparison of two popular cognitive therapies for schizophrenia, and could lead to more individualized treatment options for patients by determining which features of schizophrenia are impacted most through CRT vs. MCT. Future research combining CRT and MCT would serve as the first steps in the development of a comprehensive treatment program involving treatment with medications in conjunction with cognitive training.
Programme
Doctoral Research Award - Priority Announcement - Schizophrenia (SHOPP)
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
272868
Name
Lavigne Katie M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Mind Foundation of BC
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Differential effects of cognitive remediation therapy and metacognitive training on symptoms, cognition, and functional brain activity in schizophrenia
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$52,500
Cihrequipment2
$0
Programname2
Doctoral Research Award - Priority Announcement - Schizophrenia (SHOPP)
Keyworddelim
Cognitive Biases; Cognitive Remediation Therapy; Delusions; Functional Magnetic Resonance Imaging; Metacognitive Training; Schizophrenia
Abstract
Schizophrenia is a debilitating disorder that severely impacts the lives of patients and their families. Despite major improvements to the medications used to treat schizophrenia, they are not always effective at improving symptoms, memory and attention, or social functioning. For these reasons, health professionals are actively searching for complementary treatment options that can be used alongside conventional medications. Cognitive training is one of the most common and effective of these alternative treatments, and has been found to improve symptoms, social functioning, as well as memory and attention. However, different types of therapy target different aspects of schizophrenia, and it is important to understand their distinct effects to better tailor treatment to a patient's needs. The goal of this research is to examine whether two cognitive therapies, cognitive remediation therapy (CRT) and metacognitive training (MCT), show distinct benefits to schizophrenia patients. CRT uses training and practice to improve memory and attention whereas MCT focuses on teaching patients to counteract biases in thinking that contribute to symptoms. In this study, groups of 10 schizophrenia patients will take part in either CRT or MCT over an 8-week period, and we will examine changes in social functioning, symptom severity, memory/attention, and brain activity. This research will be the first direct comparison of two popular cognitive therapies for schizophrenia, and could lead to more individualized treatment options for patients by determining which features of schizophrenia are impacted most through CRT vs. MCT. Future research combining CRT and MCT would serve as the first steps in the development of a comprehensive treatment program involving treatment with medications in conjunction with cognitive training.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lavigne, Katie M
Approvedterm
3 ans 0 mois
Cihrcontribution2
SPIR~ $52,500~ $0~